Similar articles

• Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.

  Chen C, Han CH, Sweeney M, Cowles VE. Chen C, et al. J Pharm Sci. 2013 Apr;102(4):1155-64. doi: 10.1002/jps.23467. Epub 2013 Feb 4. J Pharm Sci. 2013. PMID: 23381946 Review.
• Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.

  Irving G, Jensen M, Cramer M, Wu J, Chiang YK, Tark M, Wallace M. Irving G, et al. Clin J Pain. 2009 Mar-Apr;25(3):185-92. doi: 10.1097/AJP.0b013e3181934276. Clin J Pain. 2009. PMID: 19333167 Clinical Trial.
• Gabapentin for once-daily treatment of post-herpetic neuralgia: a review.

  Beal B, Moeller-Bertram T, Schilling JM, Wallace MS. Beal B, et al. Clin Interv Aging. 2012;7:249-55. doi: 10.2147/CIA.S23783. Epub 2012 Jul 12. Clin Interv Aging. 2012. PMID: 22866002 Free PMC article. Review.
• The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery.

  Chen C, Cowles VE, Sweeney M. Chen C, et al. Curr Clin Pharmacol. 2013 Feb 1;8(1):67-72. Curr Clin Pharmacol. 2013. PMID: 22946876 Review.
• Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.

  Gupta A, Li S. Gupta A, et al. Drugs Aging. 2013 Dec;30(12):999-1008. doi: 10.1007/s40266-013-0126-4. Drugs Aging. 2013. PMID: 24163280 Free PMC article. Clinical Trial.